U.S. flag

An official website of the United States government

NM_000257.4(MYH7):c.4377G>T (p.Lys1459Asn) AND Cardiovascular phenotype

Germline classification:
Likely benign (1 submission)
Last evaluated:
Apr 8, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000247619.11

Allele description [Variation Report for NM_000257.4(MYH7):c.4377G>T (p.Lys1459Asn)]

NM_000257.4(MYH7):c.4377G>T (p.Lys1459Asn)

Genes:
MYH7:myosin heavy chain 7 [Gene - OMIM - HGNC]
MHRT:myosin heavy chain associated RNA transcript [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q11.2
Genomic location:
Preferred name:
NM_000257.4(MYH7):c.4377G>T (p.Lys1459Asn)
Other names:
NM_000257.3(MYH7):c.4377G>T
HGVS:
  • NC_000014.9:g.23417295C>A
  • NG_007884.1:g.23367G>T
  • NM_000257.4:c.4377G>TMANE SELECT
  • NP_000248.2:p.Lys1459Asn
  • LRG_384t1:c.4377G>T
  • LRG_384:g.23367G>T
  • NC_000014.8:g.23886504C>A
  • NM_000257.2:c.4377G>T
  • NM_000257.3:c.4377G>T
  • NR_126491.1:n.735C>A
  • P12883:p.Lys1459Asn
  • c.4377G>T
Protein change:
K1459N
Links:
UniProtKB: P12883#VAR_042828; dbSNP: rs201307101
NCBI 1000 Genomes Browser:
rs201307101
Molecular consequence:
  • NM_000257.4:c.4377G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_126491.1:n.735C>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000319737Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely benign
(Apr 8, 2020)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.

Van Driest SL, Jaeger MA, Ommen SR, Will ML, Gersh BJ, Tajik AJ, Ackerman MJ.

J Am Coll Cardiol. 2004 Aug 4;44(3):602-10.

PubMed [citation]
PMID:
15358028

[Beta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy].

Laredo R, Monserrat L, Hermida-Prieto M, Fernández X, Rodríguez I, Cazón L, Alvariño I, Dumont C, Piñón P, Peteiro J, Bouzas B, Castro-Beiras A.

Rev Esp Cardiol. 2006 Oct;59(10):1008-18. Spanish. Erratum in: Rev Esp Cardiol. 2007 May;60(5):557.

PubMed [citation]
PMID:
17125710
See all PubMed Citations (7)

Details of each submission

From Ambry Genetics, SCV000319737.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024